The application of matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry (MS) directly to blood culture broth expedites the identification of bacteria. The presented method is a rapid and reliable method for identification of Gram negative bacteria directly from blood culture broth.
An important role of the clinical microbiology laboratory is to provide rapid identification of bacteria causing bloodstream infection. Traditional identification requires the sub-culture of signaled blood culture broth with identification available only after colonies on solid agar have matured. MALDI-TOF MS is a reliable, rapid method for identification of the majority of clinically relevant bacteria when applied to colonies on solid media. The application of MALDI-TOF MS directly to blood culture broth is an attractive approach as it has potential to accelerate species identification of bacteria and improve clinical management. However, an important problem to overcome is the pre-analysis removal of interfering resins, proteins and hemoglobin contained in blood culture specimens which, if not removed, interfere with the MS spectra and can result in insufficient or low discrimination identification scores. In addition it is necessary to concentrate bacteria to develop spectra of sufficient quality. The presented method describes the concentration, purification, and extraction of Gram negative bacteria allowing for the early identification of bacteria from a signaled blood culture broth.
Patients with bloodstream infection (BSI) due to bacteria continue to have high in-hospital mortality, ranging from 6-48%1. The delivery of appropriate empiric antibiotic promotes survival and in the subset of patients with severe sepsis, each hour delay to appropriate therapy correlates to decreased survival2,3. Accordingly, a key objective of the clinical laboratory is to rapidly detect, identify and communicate the presence of bacteria in blood cultures to inform clinical decisions. It has been demonstrated that the microbiology laboratory has the greatest influence on antimicrobial therapy at the time of reporting the Gram stain4 and recently, an observational study demonstrated that matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) performed directly on blood culture broths influence prescribing in over one third of BSI caused by Gram negative bacteria5.
The commercial development of MALDI-TOF MS has led to an efficacious laboratory tool for the identification of microorganisms6,7. The technology is now well established and has been integrated into many laboratories for rapid and accurate identification of microorganisms isolated on solid media6,8. The direct application of MALDI-TOF MS to blood culture (BC) broth that have signaled “positive” for microorganisms appeals to both clinicians and laboratory managers because of the potential to obtain an earlier identification of microorganisms at low cost.
The clinical utility of direct application of MALDI-TOF MS to blood culture broth has been limited by the wide range of sensitivities observed when compared with standard phenotypic culture based methods of identification, with reports of successful identification of Gram negative bacteria ranging from 47-98.9%9-11. The variation in sensitivity likely relates to the BC broth composition, initial bacterial concentration, variation in sample preparation methods as well as the array of Gram negative organisms encountered in study populations9. Compared with these other published protocols the method presented here avoids the use of ethanol, ammonium chloride or additional (non-matrix) acetonitrile. As a result the bacterial pellet will remain viable (until the point of protein extraction) allowing for potential phenotypic susceptibility testing methods to be applied directly to these organisms in broth. In addition, the presented method has been shown to be inexpensive, reliable and rapid with bacterial identification available within 25 min of the blood culture Gram stain results, with minimal ‘hands on’ time12.
This method is a simple in-house spin-lysis protocol utilizing formic acid extraction applied directly to positive blood culture broths to identify Gram negative bacteria with MALDI-TOF MS technology.
1. Blood Culture Broths Flag as “Positive”
2. Gram Stain is Prepared
3. Transfer of Flagged Blood Culture Broth to a Serum Separating Tube
4. Concentration of Blood Culture Broth
5. Repeat Centrifugation Wash Steps
6. Lysis of Residual Cells
7. Extraction of Bacterial Proteins
8. Preparation of MALDI-TOF Target Plate
9. Place MALDI-TOF Target Plate into the Mass Spectrometer
10. MALDI-TOF MS Spectra Acquisition
11. Post Analysis Interpretation of MALDI-TOF MS Scores
12. Removal of MALDI-TOF Target Plate
The generated MALDI-TOF MS spectra are compared to the integrated reference database of spectra. A logarithmic score is assigned for the confidence of the match between the test isolate and the reference database isolates, with the recommendation of a score ≥1.7 required for probable identification to genera level (Figure 1) and ≥2.0 for probable identification to species (Figure 2). Report to species level when the score ≥1.7 and the first 5 identifications matched by the Typing software is consistent (Figure 1)12. Figure 3 demonstrates the outcome when a blood culture broth of mixed species is analyzed, in this case Escherichia coli and Serratia marcescens. Note the top 5 matched spectra are discordant. It has been previously demonstrated that mixed genera will only be identified by this method in approximately 30% of mixed broths12. It is important to be aware that with a mixed broth it is possible for a consistent report of a single species with a high confidence score. Table 1 summarizes the previously published results from the verification study of this method in which 91.8% of monomicrobial broths achieved a MALDI-TOF score of >1.7, with 100% and 97.0% concordance to genus and species, respectively12.
Figure 1. The MALDI-TOF MS generated spectra for Escherichia coli with a logarithmic score of 1.861. To the right is the first 5 matches identified by the Typing software. Note that the species is consistently reported as Escherichia coli. With the score of 1.861 and with the top 5 matches being E. coli the identification is considered reliable to species level12. Please click here to view a larger version of this figure.
Figure 2. The MALDI-TOF MS generated spectra for Pseudomonas aeruginosa with a logarithmic score of 2.216. To the right is the first 5 matches identified by the Typing software. Note that the species is consistently reported as Pseudomonas aeruginosa. With the high score of 2.216 the identification is considered reliable to species level of identification. Please click here to view a larger version of this figure.
Figure 3. The MALDI-TOF MS generated spectra for a mixed blood culture broth containing Escherichia coli and Serratia marcescens. To the right are the first 5 matches identified by the Typing software which reports both Escherichia coli and Serratia marcescens in the first 5 matched spectra. This mixed genera is only identified in approximately one-third of mixed broth cultures12. Improved versions of software in the future may improve the detection of mixed cultures. Please click here to view a larger version of this figure.
Table 1. Verification data comparing MALDI-TOF MS performed directly on blood culture broth with subsequent phenotypic identification on subcultured colonies. Concordant identification required a mass spectrometry score on blood culture broth ≥1.7. This table is adapted from a previous publication12. Please click here to view a larger version of this figure.
It is important when applying MALDI-TOF MS to blood culture broth that the post centrifugation steps are performed with sufficient care not to remix the separated components. It is particularly important to remove the blood culture constituents and human cellular proteins, including hemoglobin, which may produce spikes interfering with the MALDI-TOF spectra.
Although MS manufactures recommend cut of score of ≥2.0 for species and ≥1.7 for genus identification, other reports have suggested lower logarithmic scores (range ≥1.4 to ≥1.6) may be implemented when applied to BC broth10,12,14-18. The implementation of lower MS identification scores in clinical microbiology laboratories should only be considered following appropriate local regulatory and validation procedures.
Occasionally poor spectra are generated by this method which are either not matched, or are reported with low confidence scores. Performing duplicate or triplicate spots for each isolate can reduce the inconvenience of repeating the experiment when a single spot fails. Infrequently, all duplicate spots will not score sufficiently for identification. The cause of the poor identification may be due to incomplete database sets, or more commonly, as a result of a low starting concentration of bacteria in the blood culture broth. In a published validation set for the presented method a score of <1.7 was encountered in 8% of clinical isolates and had a slight predominance when performed on anaerobic blood culture bottles12.
MALDI-TOF MS technology is unable to separate all the clinically encountered Gram negative bacteria even when isolated on solid media. For example, E. coli will not be distinguished from Shigella species and the Salmonella genera cannot be speciated. As outlined in the results it is important to recognize that when using MALDI-TOF directly on blood culture broth the sensitivity for detection of mixed species is low11,12,18,19.
Overall, this approach offers a rapid, inexpensive, and reliable method for identifying over 90% of Gram negative blood culture isolates within 25 min of a blood culture broth signaling.
The authors have nothing to disclose.
BACTEC Plus Aerobic/F Medium | Becton Dickinson; BD, Franklin Lakes, NJ, USA | 442192 | |
BACTEC Lytic/10 Anaerobic /F Medium | Becton Dickinson; BD, Franklin Lakes, NJ, USA | 442265 | |
BACTEC Peds Plus Medium | Becton Dickinson; BD, Franklin Lakes, NJ, USA | 442194 | |
Vacutainer – Blood transfer device | Becton Dickinson; BD, Franklin Lakes, NJ, USA | 364880 | Single use sampling device reducing the risk of needlestick injury |
Vacutainer SST 5.0mL, Advance plus | Becton Dickinson; BD, Franklin Lakes, NJ, USA | 367954 | Serum separating tube |
Syringe 10 mL | Becton Dickinson; BD, Franklin Lakes, NJ, USA | 302143 | |
Transfer pipette | Samco, USA | 222-20S | |
Transfer pipette (fine tipped) | Samco, USA | 232-20S | |
Microcentrifuge tube (2.0 mL) | Eppendorf, Hamburg, Germany | 0030.120.094 | |
Sterile water (DNAse and RNAse free) | Life Technologies, Carlsbad, California, USA | 10977-015 | |
Formic acid | Sigma-Aldrich, St. Louis, Missouri, USA | F0507 | |
Matrix solution | Bruker Daltonics, Bremen Germany | 285074 | 10 mg/ml α-cyano-4-hydroxycinnamic acid, 50% acetonitrile, 2.5% trifluoroacetic acid |
Benchtop microflex LT MALDI-TOF MS | Bruker Daltonics, Bremen Germany | Utilizing BioTyper 3.1 (Build 65) and FlexControl 3.3 (Build 99) software |